Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$9.91 - $10.09 $22,822 - $23,237
-2,303 Reduced 0.97%
235,390 $0
Q3 2022

Nov 14, 2022

SELL
$0.22 - $9.87 $5,234 - $234,856
-23,795 Reduced 9.1%
237,693 $2.34 Billion
Q1 2022

May 16, 2022

BUY
$9.64 - $9.88 $44,421 - $45,527
4,608 Added 1.79%
261,488 $2.55 Million
Q4 2021

Feb 14, 2022

BUY
$9.65 - $10.2 $66,392 - $70,176
6,880 Added 2.75%
256,880 $2.48 Million
Q3 2021

Nov 12, 2021

BUY
$9.58 - $9.95 $2.4 Million - $2.49 Million
250,000 New
250,000 $2.46 Million

About Orion Biotech Opportunities Corp.


  • Ticker ORIA
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,000,000
  • Description
  • Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
More about ORIA
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.